Clinician Training Program for Long COVID
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a special training program for doctors can improve care for Veterans dealing with Long-COVID. The program focuses on teaching doctors to engage in meaningful conversations with patients, validate their experiences, and collaborate on a care plan. Veterans experiencing persistent COVID-19 symptoms and who have appointments with participating doctors might be suitable candidates. The trial consists of two parts, testing two different training methods: Concordant Care Training and Education Packet Training, to identify which method enhances doctors' ability to provide better care. As an unphased trial, this study offers Veterans an opportunity to contribute to improving healthcare practices for Long-COVID.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on training clinicians rather than changing participants' medication routines.
What prior data suggests that this training program is safe for clinicians and patients?
A previous study showed that Concordant Care creates positive experiences for patients with complex conditions. This approach emphasizes recognizing and understanding patients' experiences and collaborating to develop personalized care plans. These elements make it well-received because the care centers on patients' needs.
No known negative effects are directly linked to Concordant Care Training. It is important to note that this is not a drug or medical procedure. Instead, it is a training program for healthcare providers to enhance their interactions with patients. Therefore, there are no physical side effects like those associated with medications. Since it is not a traditional clinical trial, there is no specific phase for safety evidence. However, the program's design suggests it is a safe way to improve patient-provider relationships.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to improve how healthcare providers manage Long COVID through specialized training. Unlike traditional approaches that focus solely on patient treatment, this trial emphasizes equipping clinicians with enhanced skills and knowledge. The Concordant Care Training offers a hands-on approach to align care with patient needs, while the Education Packet Training provides structured learning materials. By focusing on clinician training, the trial hopes to improve patient outcomes through more personalized and informed care.
What evidence suggests that this trial's treatments could be effective for Long-COVID?
Research shows that the Concordant Care approach improves patient experiences by acknowledging their feelings, creating mutual understanding, and developing personalized care plans. Strong evidence indicates that both patients and doctors report positive experiences, especially for conditions not well understood, like Long COVID. Studies have found that when doctors use this approach, patients feel more understood and supported, leading to greater satisfaction and better adherence to care plans. In this trial, providers will be randomized to receive either Concordant Care Training or Education Packet Training. Although promising, no specialized training programs currently exist for doctors to use Concordant Care specifically for Long COVID. The goal is to adapt this approach to improve care and outcomes for Veterans dealing with this challenging condition.24678
Who Is on the Research Team?
Lisa Marie McAndrew, PhD
Principal Investigator
East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ
Are You a Good Fit for This Trial?
This trial is for English-speaking VA primary care providers and Veterans with Long-COVID who are receiving care in the VA. Providers must not have prior Concordant Care training, and Veterans need to have an upcoming appointment within 1-6 months after clinician consent.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training and Optimization
Part 1 of the study will optimize and test if a Concordant Care training improves VA clinicians' engagement in recommended practices to provide Concordant Care for Veterans with Long-COVID.
Randomized Parallel Cluster Trial
Part 2 of the study will determine if Concordant Care training increases clinicians' engagement in recommended practices and explore the effectiveness of Concordant Care on care outcomes.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Concordant Care Training
- Education Packet Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor